OQS
ATXS

Occudo Quantitative Strategies’s Astria Therapeutics ATXS Stock Holding History

Occudo Quantitative Strategies’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,341
Closed -$103K – 1130
2022
Q1 		$103K Sell
15,341
-116
-0.8% -$691 0.01% 1018
2021
Q4 		$83K Hold
15,457
– – 0.01% 973
2021
Q3 		$137K Buy
15,457
+9,613
+164% +$92.1K 0.02% 899
2021
Q2 		$74K Buy
+5,844
New +$75.9K 0.01% 823

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Occudo Quantitative Strategies's ATXS Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Astria Therapeutics (ATXS) in Q2 2022, closing a stake of 15,341 shares — an estimated $103K sold.

Occudo Quantitative Strategies first reported a position in ATXS in Q2 2021 and held it in 4 quarters. The position peaked at $137K in Q3 2021. 30 funds tracked by Wall St. Rank hold ATXS as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Astria Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 15,341 Astria Therapeutics shares in Q2 2022, an estimated $103K.
  • Occudo Quantitative Strategies first reported a position in Astria Therapeutics in Q2 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Astria Therapeutics position peaked at $137K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.